News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SARGEN GREGORY
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on Avid Bioservices, Inc.|
Txns:
| Granted 10,030 options to buy
@ $10.72, valued at
$107.5k
Granted 2,379 restricted stock units
@ $0 |
|
| 06/11/2020 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $35, valued at
$315k
|
|
| 01/13/2020 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on Avid Bioservices, Inc.|
Txns:
| Granted 19,675 options to buy
@ $6.87, valued at
$135.2k
|
|
| 01/13/2020 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on ArTara Therapeutics, Inc.|
Txns:
| Granted 31,000 shares
@ $0 |
|
| 01/13/2020 |
3
| SARGEN GREGORY (Director) has filed a Form 3 on ArTara Therapeutics, Inc. |
| 12/05/2019 |
4
| SARGEN GREGORY (CFO & EVP, Corp. Dev.) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 43,500 shares
@ $0
Sold 165,925 shares
@ $60, valued at
$10M
Exercised 7,500 options to buy
@ $17.81, valued at
$133.6k
Exercised 15,000 options to buy
@ $41.36, valued at
$620.4k
Exercised 22,500 options to buy
@ $40.65, valued at
$914.6k
Exercised 25,000 options to buy
@ $45.635, valued at
$1.1M
Exercised 20,000 options to buy
@ $53.605, valued at
$1.1M
|
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2018 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on Avid Bioservices, Inc.|
Txns:
| Granted 19,600 options to buy
@ $5.22, valued at
$102.3k
|
|
| 10/26/2018 |
4
| SARGEN GREGORY (EVP, Corporate Development) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 20,000 options to buy
@ $53.605, valued at
$1.1M
|
|
| 05/09/2018 |
4
| SARGEN GREGORY (EVP, Corporate Development) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 30,000 shares
@ $0
Sold 23,002 shares
@ $49.4618, valued at
$1.1M
Granted 7,500 shares
@ $16.905, valued at
$126.8k
Granted 7,500 shares
@ $17.81, valued at
$133.6k
Granted 15,000 shares
@ $41.36, valued at
$620.4k
Granted 7,500 shares
@ $40.65, valued at
$304.9k
Sold 10,565 shares
@ $49.05, valued at
$518.2k
Sold 33,933 shares
@ $49.6254, valued at
$1.7M
Exercised 7,500 options to buy
@ $16.905, valued at
$126.8k
Exercised 7,500 options to buy
@ $17.81, valued at
$133.6k
Exercised 15,000 options to buy
@ $41.36, valued at
$620.4k
|
|
| 11/29/2017 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Granted 75,000 options to buy
@ $4.67, valued at
$350.3k
|
|
| 11/29/2017 |
3
| SARGEN GREGORY (Director) has filed a Form 3 on PEREGRINE PHARMACEUTICALS INC |
| 11/01/2017 |
4
| SARGEN GREGORY (EVP, Corporate Development) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 25,000 options to buy
@ $45.635, valued at
$1.1M
|
|
| 02/08/2017 |
4
| SARGEN GREGORY (EVP, Corporate Development) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 30,000 shares
@ $0
Sold 30,000 shares
@ $54.88, valued at
$1.6M
|
|
| 11/14/2016 |
4
| SARGEN GREGORY (Executive Vice President & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 22,500 shares
@ $52.02, valued at
$1.2M
Exercised 7,500 options to buy
@ $12.46, valued at
$93.5k
Exercised 7,500 options to buy
@ $16.91, valued at
$126.8k
Exercised 7,500 options to buy
@ $17.81, valued at
$133.6k
|
|
| 10/28/2016 |
4
| SARGEN GREGORY (Executive Vice President & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 30,000 options to buy
@ $40.65, valued at
$1.2M
|
|
| 03/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/12/2013 |
4
| SARGEN GREGORY (EVP & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 100 shares
@ $19.07, valued at
$1.9k
Sold 400 shares
@ $19.05, valued at
$7.6k
Sold 100 shares
@ $19.03, valued at
$1.9k
Sold 100 shares
@ $19.02, valued at
$1.9k
Sold 604 shares
@ $19.01, valued at
$11.5k
Sold 411 shares
@ $18.99, valued at
$7.8k
Sold 200 shares
@ $18.98, valued at
$3.8k
Sold 1,200 shares
@ $18.97, valued at
$22.8k
Sold 1,063 shares
@ $18.96, valued at
$20.2k
Sold 15,822 shares
@ $18.9, valued at
$299k
Exercised 20,000 options to buy
@ $5.51, valued at
$110.2k
|
|
| 10/30/2013 |
4
| SARGEN GREGORY (Executive Vice President & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 30,000 options to buy
@ $16.905, valued at
$507.2k
|
|
| 05/08/2013 |
4
| SARGEN GREGORY (Executive Vice President & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 2,500 shares
@ $12.4201, valued at
$31.1k
Exercised 2,500 options to buy
@ $7.39, valued at
$18.5k
|
|
| 10/26/2012 |
4
| SARGEN GREGORY (Executive Vice President & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 30,000 options to buy
@ $12.46, valued at
$373.8k
|
|
| 10/20/2011 |
4
| SARGEN GREGORY (Executive Vice President & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 25,000 options to buy
@ $5.72, valued at
$143k
|
|
| 04/23/2010 |
4
| SARGEN GREGORY (Vice President & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Exercised 50,000 options to buy
@ $4.38, valued at
$219k
|
|
| 02/16/2010 |
4
| SARGEN GREGORY (Vice President & CFO) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 22,684 shares
@ $0 |
|
|
|